Company / CIK 0001682852
Moderna, Inc.
- Ticker
- MRNA
- Size, estimated from filings
- Large cap ($10B – $200B)
- Insiders on file
- 13
- Members of Congress who traded it
- 1
- Federal contracts on record
- none matched
- Lobbying filings on record
- 13
- SEC filings
- EDGAR ↗
- Latest trade on record
- October 15, 2026
Moderna, Inc. (MRNA) has 13 insiders on file who disclosed 255 transactions in the last 12 months (0 open-market buys, 75 sales, about $123.1M at reported prices), and 3 congressional trades in its stock are on record. No federal contract award that started in the last 180 days was found for a recipient with exactly this name, and 7 lobbying filings naming it as client report $640K in 2026.
Moderna, Inc. in charts
Who is trading this stock
Which people account for the buying and selling over the last 12 months?
BoughtSold
7 people account for the disclosed buying and selling in Moderna, Inc. over the last 12 months; the most active is Hoge Stephen with $48M.
Lobbying spend by quarter
How much has Moderna, Inc. reported spending on federal lobbying?
Moderna, Inc. reported $1.0M in lobbying over the last eight quarters, from filings matched by exact company name.
Insiders
| Name | Role | Rows | Bought | Sold | Last filed |
|---|---|---|---|---|---|
| Hoge Stephen | President | 76 | 0 | 23 | October 16, 2026 |
| Mock James M | Chief Financial Officer | 68 | 0 | 23 | October 7, 2026 |
| Klinger Shannon Thyme | Chief Legal Officer | 64 | 0 | 21 | September 8, 2026 |
| Bancel Stephane | Chief Executive Officer | 15 | 0 | 5 | August 7, 2026 |
| McDonnell Michael R. | Director | 3 | 0 | 0 | July 10, 2026 |
| Banque Soria Ester | Chief Commercial Officer | 2 | 0 | 0 | July 7, 2026 |
| AFEYAN NOUBAR | Director | 7 | 0 | 2 | May 22, 2026 |
| Tallett Elizabeth E | Director | 3 | 0 | 0 | May 8, 2026 |
| Nader Francois | Director | 4 | 0 | 0 | May 8, 2026 |
| NABEL ELIZABETH G | Director | 3 | 0 | 0 | May 8, 2026 |
| Hussain Abbas | Director | 7 | 0 | 2 | May 8, 2026 |
| Rubenstein David M. | Director | 4 | 0 | 0 | May 8, 2026 |
| Horning Sandra | Director | 4 | 0 | 0 | May 8, 2026 |
Rows are this company's Form 4 rows for each person. "Bought" and "sold" count open-market purchases (code P) and sales only. More in insider buying and insider selling.
Members of Congress who traded MRNA
From periodic transaction reports that name the company's stock. Amounts are the sums of the ranges as filed. Every row is on the MRNA page.
| Member | Seat | Trades | Bought | Sold | Range as filed | Latest |
|---|---|---|---|---|---|---|
| Maria Elvira Salazar | Representative (FL, District 27), Republican | 3 | 1 | 2 | $3,003–$45K | September 24, 2026 |
Insider transactions
| Filer | Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hoge Stephen | MRNA | Option / conversion M | October 15, 2026 | October 16, 2026 | 1d | 76,452 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Hoge Stephen | MRNA | Option / conversion M | October 14, 2026 | October 16, 2026 | 2d | 76,453 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Hoge Stephen | MRNA | Sell S | October 15, 2026 | October 16, 2026 | 1d | 39,145 | $221 | $8.6M | 10b5-1 plan | Form 4 ↗ | |
| Hoge Stephen | MRNA | Option / conversion M | October 15, 2026 | October 16, 2026 | 1d | 76,452 | $12 | $933K | 10b5-1 plan | Form 4 ↗ | |
| Hoge Stephen | MRNA | Sell S | October 14, 2026 | October 16, 2026 | 2d | 450 | $214 | $96K | 10b5-1 plan | Form 4 ↗ | |
| Hoge Stephen | MRNA | Sell S | October 14, 2026 | October 16, 2026 | 2d | 38,774 | $213 | $8.3M | 10b5-1 plan | Form 4 ↗ | |
| Hoge Stephen | MRNA | Option / conversion M | October 14, 2026 | October 16, 2026 | 2d | 76,453 | $12 | $933K | 10b5-1 plan | Form 4 ↗ | |
| Mock James M | MRNA | Option / conversion M | October 5, 2026 | October 7, 2026 | 2d | 1,454 | — | — | derivative | Form 4 ↗ | |
| Mock James M | MRNA | Sell F | October 5, 2026 | October 7, 2026 | 2d | 704 | $190 | $134K | Form 4 ↗ | ||
| Mock James M | MRNA | Option / conversion M | October 5, 2026 | October 7, 2026 | 2d | 1,454 | — | — | Form 4 ↗ | ||
| Hoge Stephen | MRNA | Option / conversion M | September 15, 2026 | September 16, 2026 | 1d | 76,452 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Hoge Stephen | MRNA | Option / conversion M | September 14, 2026 | September 16, 2026 | 2d | 76,453 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Hoge Stephen | MRNA | Sell S | September 15, 2026 | September 16, 2026 | 1d | 40,281 | $146 | $5.9M | 10b5-1 plan | Form 4 ↗ | |
| Hoge Stephen | MRNA | Option / conversion M | September 15, 2026 | September 16, 2026 | 1d | 76,452 | $12 | $933K | 10b5-1 plan | Form 4 ↗ | |
| Hoge Stephen | MRNA | Sell S | September 14, 2026 | September 16, 2026 | 2d | 40,294 | $144 | $5.8M | 10b5-1 plan | Form 4 ↗ | |
| Hoge Stephen | MRNA | Option / conversion M | September 14, 2026 | September 16, 2026 | 2d | 76,453 | $12 | $933K | 10b5-1 plan | Form 4 ↗ | |
| Mock James M | MRNA | Option / conversion M | September 10, 2026 | September 14, 2026 | 4d | 19,836 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Mock James M | MRNA | Sell S | September 10, 2026 | September 14, 2026 | 4d | 15,000 | $134 | $2.0M | 10b5-1 plan | Form 4 ↗ | |
| Mock James M | MRNA | Sell S | September 10, 2026 | September 14, 2026 | 4d | 19,836 | $134 | $2.7M | 10b5-1 plan | Form 4 ↗ | |
| Mock James M | MRNA | Option / conversion M | September 10, 2026 | September 14, 2026 | 4d | 19,836 | $31 | $614K | 10b5-1 plan | Form 4 ↗ | |
| Mock James M | MRNA | Option / conversion M | September 4, 2026 | September 8, 2026 | 4d | 11,797 | — | — | derivative | Form 4 ↗ | |
| Mock James M | MRNA | Sell F | September 4, 2026 | September 8, 2026 | 4d | 5,704 | $149 | $849K | Form 4 ↗ | ||
| Mock James M | MRNA | Option / conversion M | September 4, 2026 | September 8, 2026 | 4d | 11,797 | — | — | Form 4 ↗ | ||
| Klinger Shannon Thyme | MRNA | Option / conversion M | September 4, 2026 | September 8, 2026 | 4d | 11,797 | — | — | derivative | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Sell F | September 4, 2026 | September 8, 2026 | 4d | 5,704 | $149 | $849K | Form 4 ↗ | ||
| Klinger Shannon Thyme | MRNA | Option / conversion M | September 4, 2026 | September 8, 2026 | 4d | 11,797 | — | — | Form 4 ↗ | ||
| Klinger Shannon Thyme | MRNA | Option / conversion M | September 1, 2026 | September 3, 2026 | 2d | 2,166 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Option / conversion M | September 1, 2026 | September 3, 2026 | 2d | 3,471 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Sell F | September 1, 2026 | September 3, 2026 | 2d | 1,048 | $140 | $147K | 10b5-1 plan | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Option / conversion M | September 1, 2026 | September 3, 2026 | 2d | 2,166 | — | — | 10b5-1 plan | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Sell S | September 1, 2026 | September 3, 2026 | 2d | 3,471 | $140 | $486K | 10b5-1 plan | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Option / conversion M | September 1, 2026 | September 3, 2026 | 2d | 3,471 | $31 | $107K | 10b5-1 plan | Form 4 ↗ | |
| Mock James M | MRNA | Option / conversion M | September 1, 2026 | September 3, 2026 | 2d | 2,475 | — | — | derivative | Form 4 ↗ | |
| Mock James M | MRNA | Sell F | September 1, 2026 | September 3, 2026 | 2d | 1,197 | $140 | $168K | Form 4 ↗ | ||
| Mock James M | MRNA | Option / conversion M | September 1, 2026 | September 3, 2026 | 2d | 2,475 | — | — | Form 4 ↗ | ||
| Hoge Stephen | MRNA | Option / conversion M | September 1, 2026 | September 3, 2026 | 2d | 9,283 | — | — | derivative | Form 4 ↗ | |
| Hoge Stephen | MRNA | Sell F | September 1, 2026 | September 3, 2026 | 2d | 4,489 | $140 | $630K | Form 4 ↗ | ||
| Hoge Stephen | MRNA | Option / conversion M | September 1, 2026 | September 3, 2026 | 2d | 9,283 | — | — | Form 4 ↗ | ||
| Hoge Stephen | MRNA | Option / conversion M | August 28, 2026 | August 31, 2026 | 3d | 611 | — | — | derivative | Form 4 ↗ | |
| Hoge Stephen | MRNA | Option / conversion M | August 27, 2026 | August 31, 2026 | 4d | 1,437 | — | — | derivative | Form 4 ↗ | |
| Hoge Stephen | MRNA | Sell F | August 28, 2026 | August 31, 2026 | 3d | 296 | $143 | $42K | Form 4 ↗ | ||
| Hoge Stephen | MRNA | Option / conversion M | August 28, 2026 | August 31, 2026 | 3d | 611 | — | — | Form 4 ↗ | ||
| Hoge Stephen | MRNA | Sell F | August 27, 2026 | August 31, 2026 | 4d | 695 | $150 | $104K | Form 4 ↗ | ||
| Hoge Stephen | MRNA | Option / conversion M | August 27, 2026 | August 31, 2026 | 4d | 1,437 | — | — | Form 4 ↗ | ||
| Klinger Shannon Thyme | MRNA | Option / conversion M | August 28, 2026 | August 31, 2026 | 3d | 329 | — | — | derivative | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Option / conversion M | August 27, 2026 | August 31, 2026 | 4d | 774 | — | — | derivative | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Sell F | August 28, 2026 | August 31, 2026 | 3d | 160 | $143 | $23K | Form 4 ↗ | ||
| Klinger Shannon Thyme | MRNA | Option / conversion M | August 28, 2026 | August 31, 2026 | 3d | 329 | — | — | Form 4 ↗ | ||
| Klinger Shannon Thyme | MRNA | Sell F | August 27, 2026 | August 31, 2026 | 4d | 375 | $150 | $56K | Form 4 ↗ | ||
| Klinger Shannon Thyme | MRNA | Option / conversion M | August 27, 2026 | August 31, 2026 | 4d | 774 | — | — | Form 4 ↗ | ||
| Mock James M | MRNA | Option / conversion M | August 28, 2026 | August 31, 2026 | 3d | 329 | — | — | derivative | Form 4 ↗ | |
| Mock James M | MRNA | Option / conversion M | August 27, 2026 | August 31, 2026 | 4d | 774 | — | — | derivative | Form 4 ↗ | |
| Mock James M | MRNA | Sell F | August 28, 2026 | August 31, 2026 | 3d | 160 | $143 | $23K | Form 4 ↗ | ||
| Mock James M | MRNA | Option / conversion M | August 28, 2026 | August 31, 2026 | 3d | 329 | — | — | Form 4 ↗ | ||
| Mock James M | MRNA | Sell F | August 27, 2026 | August 31, 2026 | 4d | 375 | $150 | $56K | Form 4 ↗ | ||
| Mock James M | MRNA | Option / conversion M | August 27, 2026 | August 31, 2026 | 4d | 774 | — | — | Form 4 ↗ | ||
| Bancel Stephane | MRNA | Option / conversion M | August 6, 2026 | August 7, 2026 | 1d | 64,928 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Bancel Stephane | MRNA | Option / conversion M | August 6, 2026 | August 7, 2026 | 1d | 187,541 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Bancel Stephane | MRNA | Option / conversion M | August 5, 2026 | August 7, 2026 | 2d | 128,393 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Bancel Stephane | MRNA | Option / conversion M | August 5, 2026 | August 7, 2026 | 2d | 370,853 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Bancel Stephane | MRNA | Option / conversion M | August 6, 2026 | August 7, 2026 | 1d | 252,469 | $19 | $4.8M | 10b5-1 plan | Form 4 ↗ | |
| Bancel Stephane | MRNA | Sell S | August 5, 2026 | August 7, 2026 | 2d | 187,044 | $59 | $11.0M | 10b5-1 plan | Form 4 ↗ | |
| Bancel Stephane | MRNA | Sell S | August 5, 2026 | August 7, 2026 | 2d | 39,891 | $58 | $2.3M | 10b5-1 plan | Form 4 ↗ | |
| Bancel Stephane | MRNA | Sell S | August 5, 2026 | August 7, 2026 | 2d | 124,838 | $57 | $7.1M | 10b5-1 plan | Form 4 ↗ | |
| Bancel Stephane | MRNA | Sell S | August 5, 2026 | August 7, 2026 | 2d | 147,473 | $56 | $8.3M | 10b5-1 plan | Form 4 ↗ | |
| Bancel Stephane | MRNA | Option / conversion M | August 5, 2026 | August 7, 2026 | 2d | 499,246 | $19 | $9.6M | 10b5-1 plan | Form 4 ↗ | |
| Hoge Stephen | MRNA | Option / conversion M | July 15, 2026 | July 16, 2026 | 1d | 16,110 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Hoge Stephen | MRNA | Option / conversion M | July 15, 2026 | July 16, 2026 | 1d | 37,226 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Hoge Stephen | MRNA | Sell S | July 15, 2026 | July 16, 2026 | 1d | 53,336 | $68 | $3.6M | 10b5-1 plan | Form 4 ↗ | |
| Hoge Stephen | MRNA | Option / conversion M | July 15, 2026 | July 16, 2026 | 1d | 16,110 | $19 | $309K | 10b5-1 plan | Form 4 ↗ | |
| Hoge Stephen | MRNA | Option / conversion M | July 15, 2026 | July 16, 2026 | 1d | 37,226 | $19 | $713K | 10b5-1 plan | Form 4 ↗ | |
| McDonnell Michael R. | MRNA | Other A | July 8, 2026 | July 10, 2026 | 2d | 5,733 | — | — | derivative | Form 4 ↗ | |
| McDonnell Michael R. | MRNA | Other A | July 8, 2026 | July 10, 2026 | 2d | 1,618 | — | — | derivative | Form 4 ↗ | |
| McDonnell Michael R. | MRNA | Other A | July 8, 2026 | July 10, 2026 | 2d | 7,415 | — | — | derivative | Form 4 ↗ | |
| Banque Soria Ester | MRNA | Other A | July 5, 2026 | July 7, 2026 | 2d | 38,364 | — | — | derivative | Form 4 ↗ | |
| Banque Soria Ester | MRNA | Other A | July 5, 2026 | July 7, 2026 | 2d | 18,658 | — | — | derivative | Form 4 ↗ | |
| Mock James M | MRNA | Option / conversion M | July 2, 2026 | July 6, 2026 | 4d | 1,452 | — | — | derivative | Form 4 ↗ | |
| Mock James M | MRNA | Sell F | July 2, 2026 | July 6, 2026 | 4d | 703 | $73 | $51K | Form 4 ↗ | ||
| Mock James M | MRNA | Option / conversion M | July 2, 2026 | July 6, 2026 | 4d | 1,452 | — | — | Form 4 ↗ | ||
| Hoge Stephen | MRNA | Option / conversion M | June 15, 2026 | June 17, 2026 | 2d | 16,110 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Hoge Stephen | MRNA | Option / conversion M | June 15, 2026 | June 17, 2026 | 2d | 37,226 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Hoge Stephen | MRNA | Sell S | June 15, 2026 | June 17, 2026 | 2d | 53,336 | $51 | $2.7M | 10b5-1 plan | Form 4 ↗ | |
| Hoge Stephen | MRNA | Option / conversion M | June 15, 2026 | June 17, 2026 | 2d | 16,110 | $19 | $309K | 10b5-1 plan | Form 4 ↗ | |
| Hoge Stephen | MRNA | Option / conversion M | June 15, 2026 | June 17, 2026 | 2d | 37,226 | $19 | $713K | 10b5-1 plan | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Option / conversion M | June 5, 2026 | June 8, 2026 | 3d | 11,798 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Option / conversion M | June 4, 2026 | June 8, 2026 | 4d | 3,471 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Sell F | June 5, 2026 | June 8, 2026 | 3d | 5,705 | $52 | $294K | 10b5-1 plan | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Option / conversion M | June 5, 2026 | June 8, 2026 | 3d | 11,798 | — | — | 10b5-1 plan | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Sell S | June 4, 2026 | June 8, 2026 | 4d | 3,471 | $50 | $174K | 10b5-1 plan | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Option / conversion M | June 4, 2026 | June 8, 2026 | 4d | 3,471 | $31 | $107K | 10b5-1 plan | Form 4 ↗ | |
| Mock James M | MRNA | Option / conversion M | June 5, 2026 | June 8, 2026 | 3d | 11,798 | — | — | derivative | Form 4 ↗ | |
| Mock James M | MRNA | Sell F | June 5, 2026 | June 8, 2026 | 3d | 5,705 | $52 | $294K | Form 4 ↗ | ||
| Mock James M | MRNA | Option / conversion M | June 5, 2026 | June 8, 2026 | 3d | 11,798 | — | — | Form 4 ↗ | ||
| Mock James M | MRNA | Option / conversion M | June 1, 2026 | June 3, 2026 | 2d | 2,475 | — | — | derivative | Form 4 ↗ | |
| Mock James M | MRNA | Sell F | June 1, 2026 | June 3, 2026 | 2d | 1,197 | $47 | $56K | Form 4 ↗ | ||
| Mock James M | MRNA | Option / conversion M | June 1, 2026 | June 3, 2026 | 2d | 2,475 | — | — | Form 4 ↗ | ||
| Klinger Shannon Thyme | MRNA | Option / conversion M | June 1, 2026 | June 3, 2026 | 2d | 2,165 | — | — | derivative | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Sell F | June 1, 2026 | June 3, 2026 | 2d | 1,047 | $47 | $49K | Form 4 ↗ | ||
| Klinger Shannon Thyme | MRNA | Option / conversion M | June 1, 2026 | June 3, 2026 | 2d | 2,165 | — | — | Form 4 ↗ | ||
| Hoge Stephen | MRNA | Option / conversion M | June 1, 2026 | June 3, 2026 | 2d | 9,282 | — | — | derivative | Form 4 ↗ | |
| Hoge Stephen | MRNA | Sell F | June 1, 2026 | June 3, 2026 | 2d | 4,488 | $47 | $212K | Form 4 ↗ | ||
| Hoge Stephen | MRNA | Option / conversion M | June 1, 2026 | June 3, 2026 | 2d | 9,282 | — | — | Form 4 ↗ | ||
| Mock James M | MRNA | Option / conversion M | May 28, 2026 | May 29, 2026 | 1d | 328 | — | — | derivative | Form 4 ↗ | |
| Mock James M | MRNA | Option / conversion M | May 27, 2026 | May 29, 2026 | 2d | 773 | — | — | derivative | Form 4 ↗ | |
| Mock James M | MRNA | Sell F | May 28, 2026 | May 29, 2026 | 1d | 159 | $48 | $7,570 | Form 4 ↗ | ||
| Mock James M | MRNA | Option / conversion M | May 28, 2026 | May 29, 2026 | 1d | 328 | — | — | Form 4 ↗ | ||
| Mock James M | MRNA | Sell F | May 27, 2026 | May 29, 2026 | 2d | 374 | $47 | $18K | Form 4 ↗ | ||
| Mock James M | MRNA | Option / conversion M | May 27, 2026 | May 29, 2026 | 2d | 773 | — | — | Form 4 ↗ | ||
| Klinger Shannon Thyme | MRNA | Option / conversion M | May 28, 2026 | May 29, 2026 | 1d | 328 | — | — | derivative | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Option / conversion M | May 27, 2026 | May 29, 2026 | 2d | 773 | — | — | derivative | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Sell F | May 28, 2026 | May 29, 2026 | 1d | 159 | $48 | $7,570 | Form 4 ↗ | ||
| Klinger Shannon Thyme | MRNA | Option / conversion M | May 28, 2026 | May 29, 2026 | 1d | 328 | — | — | Form 4 ↗ | ||
| Klinger Shannon Thyme | MRNA | Sell F | May 27, 2026 | May 29, 2026 | 2d | 374 | $47 | $18K | Form 4 ↗ | ||
| Klinger Shannon Thyme | MRNA | Option / conversion M | May 27, 2026 | May 29, 2026 | 2d | 773 | — | — | Form 4 ↗ | ||
| Hoge Stephen | MRNA | Option / conversion M | May 28, 2026 | May 29, 2026 | 1d | 610 | — | — | derivative | Form 4 ↗ | |
| Hoge Stephen | MRNA | Option / conversion M | May 27, 2026 | May 29, 2026 | 2d | 1,437 | — | — | derivative | Form 4 ↗ | |
| Hoge Stephen | MRNA | Sell F | May 28, 2026 | May 29, 2026 | 1d | 295 | $48 | $14K | Form 4 ↗ | ||
| Hoge Stephen | MRNA | Option / conversion M | May 28, 2026 | May 29, 2026 | 1d | 610 | — | — | Form 4 ↗ | ||
| Hoge Stephen | MRNA | Sell F | May 27, 2026 | May 29, 2026 | 2d | 695 | $47 | $33K | Form 4 ↗ | ||
| Hoge Stephen | MRNA | Option / conversion M | May 27, 2026 | May 29, 2026 | 2d | 1,437 | — | — | Form 4 ↗ | ||
| AFEYAN NOUBAR | MRNA | Option / conversion M | May 21, 2026 | May 22, 2026 | 1d | 9,263 | — | — | indirectderivative | Form 4 ↗ | |
| AFEYAN NOUBAR | MRNA | Sell S | May 21, 2026 | May 22, 2026 | 1d | 9,263 | $47 | $434K | indirect | Form 4 ↗ | |
| AFEYAN NOUBAR | MRNA | Option / conversion M | May 21, 2026 | May 22, 2026 | 1d | 9,263 | $19 | $177K | indirect | Form 4 ↗ | |
| Hoge Stephen | MRNA | Option / conversion M | May 15, 2026 | May 18, 2026 | 3d | 16,110 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Hoge Stephen | MRNA | Option / conversion M | May 15, 2026 | May 18, 2026 | 3d | 37,226 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Hoge Stephen | MRNA | Sell S | May 15, 2026 | May 18, 2026 | 3d | 53,336 | $48 | $2.6M | 10b5-1 plan | Form 4 ↗ | |
| Hoge Stephen | MRNA | Option / conversion M | May 15, 2026 | May 18, 2026 | 3d | 16,110 | $19 | $309K | 10b5-1 plan | Form 4 ↗ | |
| Hoge Stephen | MRNA | Option / conversion M | May 15, 2026 | May 18, 2026 | 3d | 37,226 | $19 | $713K | 10b5-1 plan | Form 4 ↗ | |
| Rubenstein David M. | MRNA | Other A | May 6, 2026 | May 8, 2026 | 2d | 2,092 | — | — | derivative | Form 4 ↗ | |
| Rubenstein David M. | MRNA | Other A | May 6, 2026 | May 8, 2026 | 2d | 9,681 | — | — | derivative | Form 4 ↗ | |
| Hussain Abbas | MRNA | Other A | May 6, 2026 | May 8, 2026 | 2d | 8,371 | — | — | derivative | Form 4 ↗ | |
| Horning Sandra | MRNA | Other A | May 6, 2026 | May 8, 2026 | 2d | 2,092 | — | — | derivative | Form 4 ↗ | |
| Horning Sandra | MRNA | Other A | May 6, 2026 | May 8, 2026 | 2d | 9,681 | — | — | derivative | Form 4 ↗ | |
| NABEL ELIZABETH G | MRNA | Other A | May 6, 2026 | May 8, 2026 | 2d | 8,371 | — | — | derivative | Form 4 ↗ | |
| Nader Francois | MRNA | Other A | May 6, 2026 | May 8, 2026 | 2d | 4,185 | — | — | derivative | Form 4 ↗ | |
| Nader Francois | MRNA | Other A | May 6, 2026 | May 8, 2026 | 2d | 6,454 | — | — | derivative | Form 4 ↗ | |
| Tallett Elizabeth E | MRNA | Other A | May 6, 2026 | May 8, 2026 | 2d | 8,371 | — | — | derivative | Form 4 ↗ | |
| AFEYAN NOUBAR | MRNA | Other A | May 6, 2026 | May 8, 2026 | 2d | 12,908 | — | — | derivative | Form 4 ↗ | |
| Horning Sandra | MRNA | Option / conversion M | April 30, 2026 | May 4, 2026 | 4d | 16,233 | — | — | derivative | Form 4 ↗ | |
| Horning Sandra | MRNA | Option / conversion M | April 30, 2026 | May 4, 2026 | 4d | 16,233 | — | — | Form 4 ↗ | ||
| Rubenstein David M. | MRNA | Option / conversion M | April 30, 2026 | May 4, 2026 | 4d | 8,116 | — | — | derivative | Form 4 ↗ | |
| Rubenstein David M. | MRNA | Option / conversion M | April 30, 2026 | May 4, 2026 | 4d | 8,116 | — | — | Form 4 ↗ | ||
| Hussain Abbas | MRNA | Option / conversion M | April 30, 2026 | May 4, 2026 | 4d | 16,233 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Hussain Abbas | MRNA | Sell S | May 1, 2026 | May 4, 2026 | 3d | 5,682 | $47 | $265K | 10b5-1 plan | Form 4 ↗ | |
| Hussain Abbas | MRNA | Option / conversion M | April 30, 2026 | May 4, 2026 | 4d | 16,233 | — | — | 10b5-1 plan | Form 4 ↗ | |
| NABEL ELIZABETH G | MRNA | Option / conversion M | April 30, 2026 | May 4, 2026 | 4d | 16,233 | — | — | derivative | Form 4 ↗ | |
| NABEL ELIZABETH G | MRNA | Option / conversion M | April 30, 2026 | May 4, 2026 | 4d | 16,233 | — | — | Form 4 ↗ | ||
| Nader Francois | MRNA | Option / conversion M | April 30, 2026 | May 4, 2026 | 4d | 12,174 | — | — | derivative | Form 4 ↗ | |
| Nader Francois | MRNA | Option / conversion M | April 30, 2026 | May 4, 2026 | 4d | 12,174 | — | — | Form 4 ↗ | ||
| Tallett Elizabeth E | MRNA | Option / conversion M | April 30, 2026 | May 4, 2026 | 4d | 4,058 | — | — | derivative | Form 4 ↗ | |
| Tallett Elizabeth E | MRNA | Option / conversion M | April 30, 2026 | May 4, 2026 | 4d | 4,058 | — | — | Form 4 ↗ | ||
| Mock James M | MRNA | Option / conversion M | April 2, 2026 | April 6, 2026 | 4d | 1,453 | — | — | derivative | Form 4 ↗ | |
| Mock James M | MRNA | Sell F | April 2, 2026 | April 6, 2026 | 4d | 703 | $50 | $35K | Form 4 ↗ | ||
| Mock James M | MRNA | Option / conversion M | April 2, 2026 | April 6, 2026 | 4d | 1,453 | — | — | Form 4 ↗ | ||
| Klinger Shannon Thyme | MRNA | Option / conversion M | March 5, 2026 | March 6, 2026 | 1d | 11,797 | — | — | derivative | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Sell F | March 5, 2026 | March 6, 2026 | 1d | 5,704 | $58 | $330K | Form 4 ↗ | ||
| Klinger Shannon Thyme | MRNA | Option / conversion M | March 5, 2026 | March 6, 2026 | 1d | 11,797 | — | — | Form 4 ↗ | ||
| Mock James M | MRNA | Option / conversion M | March 5, 2026 | March 6, 2026 | 1d | 11,797 | — | — | derivative | Form 4 ↗ | |
| Mock James M | MRNA | Sell F | March 5, 2026 | March 6, 2026 | 1d | 5,704 | $58 | $330K | Form 4 ↗ | ||
| Mock James M | MRNA | Option / conversion M | March 5, 2026 | March 6, 2026 | 1d | 11,797 | — | — | Form 4 ↗ | ||
| Bancel Stephane | MRNA | Other A | March 1, 2026 | March 3, 2026 | 2d | 250,932 | — | — | derivative | Form 4 ↗ | |
| Hoge Stephen | MRNA | Other A | March 1, 2026 | March 3, 2026 | 2d | 165,230 | — | — | derivative | Form 4 ↗ | |
| Hoge Stephen | MRNA | Other A | March 1, 2026 | March 3, 2026 | 2d | 125,466 | — | — | derivative | Form 4 ↗ | |
| Hoge Stephen | MRNA | Option / conversion M | February 27, 2026 | March 3, 2026 | 4d | 37,131 | — | — | derivative | Form 4 ↗ | |
| Hoge Stephen | MRNA | Option / conversion M | February 27, 2026 | March 3, 2026 | 4d | 1,436 | — | — | derivative | Form 4 ↗ | |
| Hoge Stephen | MRNA | Option / conversion M | February 27, 2026 | March 3, 2026 | 4d | 611 | — | — | derivative | Form 4 ↗ | |
| Hoge Stephen | MRNA | Option / conversion M | February 27, 2026 | March 3, 2026 | 4d | 652 | — | — | derivative | Form 4 ↗ | |
| Hoge Stephen | MRNA | Sell F | February 27, 2026 | March 3, 2026 | 4d | 17,953 | $52 | $928K | Form 4 ↗ | ||
| Hoge Stephen | MRNA | Option / conversion M | February 27, 2026 | March 3, 2026 | 4d | 37,131 | — | — | Form 4 ↗ | ||
| Hoge Stephen | MRNA | Sell F | February 27, 2026 | March 3, 2026 | 4d | 695 | $52 | $36K | Form 4 ↗ | ||
| Hoge Stephen | MRNA | Option / conversion M | February 27, 2026 | March 3, 2026 | 4d | 1,436 | — | — | Form 4 ↗ | ||
| Hoge Stephen | MRNA | Sell F | February 27, 2026 | March 3, 2026 | 4d | 296 | $52 | $15K | Form 4 ↗ | ||
| Hoge Stephen | MRNA | Option / conversion M | February 27, 2026 | March 3, 2026 | 4d | 611 | — | — | Form 4 ↗ | ||
| Hoge Stephen | MRNA | Sell F | February 27, 2026 | March 3, 2026 | 4d | 316 | $52 | $16K | Form 4 ↗ | ||
| Hoge Stephen | MRNA | Option / conversion M | February 27, 2026 | March 3, 2026 | 4d | 652 | — | — | Form 4 ↗ | ||
| Klinger Shannon Thyme | MRNA | Option / conversion M | March 2, 2026 | March 3, 2026 | 1d | 13,885 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Other A | March 1, 2026 | March 3, 2026 | 2d | 38,553 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Other A | March 1, 2026 | March 3, 2026 | 2d | 29,275 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Option / conversion M | February 27, 2026 | March 3, 2026 | 4d | 8,663 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Option / conversion M | February 27, 2026 | March 3, 2026 | 4d | 774 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Option / conversion M | February 27, 2026 | March 3, 2026 | 4d | 329 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Option / conversion M | February 27, 2026 | March 3, 2026 | 4d | 233 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Sell S | March 2, 2026 | March 3, 2026 | 1d | 13,885 | $52 | $726K | 10b5-1 plan | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Option / conversion M | March 2, 2026 | March 3, 2026 | 1d | 13,885 | $31 | $430K | 10b5-1 plan | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Sell F | February 27, 2026 | March 3, 2026 | 4d | 4,189 | $52 | $217K | 10b5-1 plan | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Option / conversion M | February 27, 2026 | March 3, 2026 | 4d | 8,663 | — | — | 10b5-1 plan | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Sell F | February 27, 2026 | March 3, 2026 | 4d | 375 | $52 | $19K | 10b5-1 plan | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Option / conversion M | February 27, 2026 | March 3, 2026 | 4d | 774 | — | — | 10b5-1 plan | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Sell F | February 27, 2026 | March 3, 2026 | 4d | 160 | $52 | $8,274 | 10b5-1 plan | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Option / conversion M | February 27, 2026 | March 3, 2026 | 4d | 329 | — | — | 10b5-1 plan | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Sell F | February 27, 2026 | March 3, 2026 | 4d | 113 | $52 | $5,843 | 10b5-1 plan | Form 4 ↗ | |
| Klinger Shannon Thyme | MRNA | Option / conversion M | February 27, 2026 | March 3, 2026 | 4d | 233 | — | — | 10b5-1 plan | Form 4 ↗ | |
| Mock James M | MRNA | Other A | March 1, 2026 | March 3, 2026 | 2d | 49,569 | — | — | derivative | Form 4 ↗ | |
| Mock James M | MRNA | Other A | March 1, 2026 | March 3, 2026 | 2d | 37,639 | — | — | derivative | Form 4 ↗ | |
| Mock James M | MRNA | Option / conversion M | February 27, 2026 | March 3, 2026 | 4d | 9,901 | — | — | derivative | Form 4 ↗ | |
| Mock James M | MRNA | Option / conversion M | February 27, 2026 | March 3, 2026 | 4d | 774 | — | — | derivative | Form 4 ↗ | |
| Mock James M | MRNA | Option / conversion M | February 27, 2026 | March 3, 2026 | 4d | 329 | — | — | derivative | Form 4 ↗ | |
| Mock James M | MRNA | Sell F | February 27, 2026 | March 3, 2026 | 4d | 4,788 | $52 | $248K | Form 4 ↗ | ||
| Mock James M | MRNA | Option / conversion M | February 27, 2026 | March 3, 2026 | 4d | 9,901 | — | — | Form 4 ↗ | ||
| Mock James M | MRNA | Sell F | February 27, 2026 | March 3, 2026 | 4d | 375 | $52 | $19K | Form 4 ↗ |
Showing the 200 most recent of 260.
Federal contracts (USAspending, awards started in the last 180 days)
No contract award starting in the last 180 days was found for a recipient named exactly "Moderna, Inc.". Subsidiaries and differently-spelled recipients are not matched — search contracts.
Lobbying (Senate LDA, as client)
| Period | Registrant | Primary issue | Amount | Source |
|---|---|---|---|---|
| 2026 Q3 | HOLLAND & KNIGHT LLP | Taxation/Internal Revenue Code | $20,000 | LDA ↗ |
| 2026 Q2 | MODERNA, INC. | Health Issues | $290,000 | LDA ↗ |
| 2026 Q2 | AVENUE SOLUTIONS | Health Issues | $50,000 | LDA ↗ |
| 2026 Q2 | HOLLAND & KNIGHT LLP | Taxation/Internal Revenue Code | $20,000 | LDA ↗ |
| 2026 Q1 | MODERNA, INC. | Health Issues | $190,000 | LDA ↗ |
| 2026 Q1 | AVENUE SOLUTIONS | Health Issues | $50,000 | LDA ↗ |
| 2026 Q1 | HOLLAND & KNIGHT LLP | Taxation/Internal Revenue Code | $20,000 | LDA ↗ |
| 2025 Q4 | MODERNA, INC. | Health Issues | $130,000 | LDA ↗ |
| 2025 Q4 | AVENUE SOLUTIONS | Health Issues | $50,000 | LDA ↗ |
| 2025 Q4 | HOLLAND & KNIGHT LLP | Taxation/Internal Revenue Code | $20,000 | LDA ↗ |
| 2025 Q3 | MODERNA, INC. | Health Issues | $100,000 | LDA ↗ |
| 2025 Q3 | AVENUE SOLUTIONS | Health Issues | $50,000 | LDA ↗ |
| 2025 Q3 | HOLLAND & KNIGHT LLP | Taxation/Internal Revenue Code | $20,000 | LDA ↗ |
Related companies
Companies whose stock was traded by the same people who traded MRNA, by number of filers in common. It shows overlap in public filings and nothing else.
- Datadog, Inc. DDOG 1 filer in common
- Meta Platforms, Inc. META 1 filer in common
- Snowflake Inc. SNOW 1 filer in common
- Salesforce, Inc. CRM 1 filer in common
- Okta, Inc. OKTA 1 filer in common
- CHEVRON CORP CVX 1 filer in common
- CORNING INC /NY GLW 1 filer in common
- Marvell Technology, Inc. MRVL 1 filer in common
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Lobbying disclosure reports Reports are due about 20 days after each quarter ends.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| House Clerk, periodic transaction reports | 2 | 3 | September 9, 2026 | October 7, 2026 | House Clerk search |
| SEC EDGAR, Form 4 | 66 | 260 | October 6, 2025 | October 16, 2026 | Form 4 list on EDGAR |
| Lobbying disclosure filings | 13 filings | — | — | — | LDA.gov search |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Insiders and their transactions come from SEC EDGAR Form 4 filings for this issuer. Contracts and lobbying are matched by exact normalized name (suffixes like Inc./Corp. ignored) to USAspending recipients and LDA clients — a conservative match that misses subsidiaries on purpose. See methodology and corrections.
Not investment advice. Public records shown as filed; no recommendation is made or implied.